K Number
K981958
Device Name
LEISEGANG VIDEO COLPOSCOPE
Manufacturer
Date Cleared
1998-10-19

(137 days)

Product Code
Regulation Number
884.1630
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.
Device Description
The Galileo Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor. The Leisegang Video Colposcope consists of a CCD camera with a halogen light source, green filter and is mounted on a mobile base.
More Information

No
The summary describes a standard video colposcope with a camera and light source, and there is no mention of AI, ML, image processing, or any related performance metrics or training/test data.

No.
The device is used for magnified viewing and diagnosis, not for treating conditions.

Yes
The device is described as being "intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities." The purpose to "diagnose abnormalities" indicates its use as a diagnostic device.

No

The device description explicitly states it consists of a CCD camera, halogen light source, green filter, and a mobile base, which are all hardware components.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD devices are used to examine specimens taken from the human body. This device is used to examine tissues within the human body (vagina, cervix, external genitalia) directly.
  • The intended use describes direct visualization of tissues. It doesn't mention analyzing blood, urine, tissue samples, or any other specimen.
  • The device description confirms it's a camera and light source for direct viewing.

This device is a medical device used for diagnostic imaging, but it falls under a different regulatory category than IVDs.

N/A

Intended Use / Indications for Use

The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.

Product codes

85 HEX

Device Description

The Galileo Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.

The Leisegang Video Colposcope consists of a CCD camera with a halogen light source, green filter and is mounted on a mobile base.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

vagina, cervix and external genitalia

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K940094, K955635

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 884.1630 Colposcope.

(a)
Identification. A colposcope is a device designed to permit direct viewing of the tissues of the vagina and cervix by a telescopic system located outside the vagina. It is used to diagnose abnormalities and select areas for biopsy. This generic type of device may include a light source, cables, and component parts.(b)
Classification. Class II (special controls). The device, when it is a standard colposcope (or colpomicroscope) that uses only a white light source, does not use filters other than a green filter, does not include image analysis software, and is not smartphone-based, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.

0

510(k) SUMMARY FOR LEISEGANG VIDEO COLPOSCOPE

SPONSOR/APPLICANT NAME, ADDRESS, TELEPHONE NUMBER 1.

Leisegang Medical, Inc. 6401 Congress Avenue Boca Raton, Florida Telephone (561) 994-0202 (561) 994-6603 Facsimile

Contact Person:

Debbie Iampietro Director of Quality Assurance

Date of Summary Preparation:

June 3, 1998

    1. DEVICE NAME
      Leisegang Video Colposcope Proprietary Name: Colposcope Common/Usual Name: . . . Colposcope and Accessories Classification Name:

3. IDENTIFICATION OF THE PREDICATE OR LEGALLY MARKETED DEVICE(S) TO WHICH EQUIVALENCE IS BEING CLAIMED

Leisegang Model 1D Colposcope, manufactured by Leisegang Medical, Inc., K940094 and the Model 88000 and 89000 Video Colposcopes, manufactured by Welch Allyn, Inc. K955635.

1

DEVICE DESCRIPTION 4.

The Galileo Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.

The Leisegang Video Colposcope consists of a CCD camera with a halogen light source, green filter and is mounted on a mobile base.

5. INTENDED USE

The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed on a color monitor.

A STATEMENT OF HOW THE TECHNOLOGICAL CHARACTERISTICS OF THE DEVICE 6. Compare to Those of the Predicate or Legally Marketed Device(s) CITED

The Galileo, Leisegang and Welch Allyn Colposcopes are all intended to permit viewing and imaging of the tissues of the vagina and cervix to diagnose abnormalities and select areas for biopsy. While the predicate Leisegang devices are video adaptable, the Welch Allyn and the proposed Galileo Leisegang devices contain integrated imaging systems. These imaging systems provide the physician with a means to record pictures of the tissues for review over time.

All three devices function as non-patient contacting Colposcopes with working distances of 250 to 307 mm. The proposed Leisegang and the predicate Leisegang devices are standard Colposcopes in that the tissue is magnified and viewed directly via binocular microscopes with the option of using a video monitor. Operation of the Welch Allyn device differs in that the target image is always projected onto a video monitor rather than viewed directly through eyepieces.

All three devices have imaging capabilities. The predicate Leisegang Colposcopes have a video adaptor to allow for recording of the examination procedure. The video system of the proposed Galileo Leisegang and the Welch Allyn colposcopes are integral to its operation as the tissue can only be viewed by way of the video

2

monitor. A VCR/Video Printer can be used to produce hard copies of images obtained using both the proposed and predicate Leisegang and Welch Allyn Colposcopes.

3

Image /page/3/Picture/0 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features an abstract eagle design, with three stylized lines forming the body and wings. The words "DEPARTMENT OF HEALTH & HUMAN..." are arranged in a circular pattern around the left side of the eagle. The letters "USA" are on the right side of the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

OCT 1 9 1998

Ms. Debbie Iampietro Director of QA/RA Galileo Corporation Galileo Park P.O. Box 550 Sturbridge, MA 01566 Re: K981958

Galileo Corporation Leisegang Video Colposcopes Dated: September 10, 1998 Received: September 11, 1998 Regulatory Class: II 21 CFR 884.1630/Procode: 85 HEX

Dear Ms. Iampietro:

We have reviewed your Section 510/k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510kk) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmadsmain.html".

Sincerely yours.

Lillian Yin, Ph.D.

Director, Division of Reproductive, Abdominal. Ear. Nose and Throat and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

510(k) Number (if known): ≤981958

Leisegang Video Colposcope Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications For Use:

The Leisegang Video Colposcope is intended for magnified viewing of the tissues of the vagina, cervix and external genitalia in order to diagnose abnormalities and select areas for biopsy. The image can be viewed only on a color monitor.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David A. Segmen

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices K981958 15001 510(k) Number_

Prescription UseV
(Per 21 CFR 801.109)

Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)